GDUFA Research Outcomes
PBPK Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to physiologically-based pharmacokinetics (PBPK) computational modeling to support generic product development and assessment.
- 
                        Advancing the Use of Model-Integrated Evidence in Generic Drug Development and Assessment
                        Zhao, Liang 
- 
                        The Development and Framework of MMF as a Regulatory Initiative
                        Zhao, Liang 
- 
                        Regulatory Perspective: What Can Be a Model Master File and How to Share It?
                        Zhao, Liang 
- 
                        Symposium 18: Partial Area Under the Curve Analysis in Generic & New Drug Development
                        Gallicano, Keith 
- 
                        Quantitative Methods and Modeling to Support GDUFA Regulatory Science Research Program
                        Zhao, Liang 
- 
                        Regulatory Challenges and Opportunities for Model-based Approaches for Patient Pharmacokinetic (PK) Studies with Sparse Sampling Design
                        Zhao, Liang 
- 
                        Challenges in Using PBPK Models for Locally Acting Drug Products to Inform Regulatory Decision Making
                        Zhao, Liang 
- 
                        IVRT Studies During Topical Product Development: Lifecycle Management for SUPAC-SS and Generics
                        Yen, Cristina 
- 
                        IVPT Studies with Sunscreen Products: Experimental Parameters
                        Yang, Yang 
- 
                        Using PBPK Model to Support Risk Assessment for Oral Products, from a Regulatory Perspective
                        Wu, Fang